Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael A Tortorici

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Expert Review of Clinical Pharmacology|May 31, 2014
Kidney function assessment and its role in drug development, review and utilizationMichael A Tortorici, Thomas D Nolin
Critical Care Medicine|September 15, 2007
Effects of hypothermia on drug disposition, metabolism, and response: A focus of hypothermia-mediated alterations on the cytochrome P450 enzyme systemMichael A Tortorici, Patrick M Kochanek, Samuel M Poloyac
Journal of Clinical Pharmacology|January 11, 2012
Design, conduct, analysis, and interpretation of clinical studies in patients with impaired kidney functionMichael A Tortorici, David Cutler, Lei Zhang, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 14, 2018
CSL112 (Apolipoprotein A-I [Human]) Enhances Cholesterol Efflux Similarly in Healthy Individuals and Stable Atherosclerotic Disease PatientsAndreas Gille, Denise D'Andrea, Michael A Tortorici, et al.
European Journal of Clinical Pharmacology|October 12, 2012
The evaluation of potential pharmacokinetic interaction between sirolimus and tacrolimus in healthy volunteersMichael A Tortorici, Virginia Parks, Kyle Matschke, et al.
Immunological Medicine|December 19, 2019
Pharmacokinetic properties of Privigen<sup>®</sup> in Japanese patients with primary immunodeficiencyTomohiro Morio, Gautam Baheti, Michael A Tortorici, et al.
Critical Care Medicine|March 8, 2006
Therapeutic hypothermia-induced pharmacokinetic alterations on CYP2E1 chlorzoxazone-mediated metabolism in a cardiac arrest rat modelMichael A Tortorici, Patrick M Kochanek, Robert R Bies, et al.
Clinical Therapeutics|January 9, 2020
Pharmacometric Analysis of IgPro10 in Japanese and Non-Japanese Patients With Primary ImmunodeficiencyDandan Luo, Gautam Baheti, Michael A Tortorici, et al.
Journal of Clinical Pharmacology|August 20, 2016
Dosage Adjustments Related to Young or Old Age and Organ ImpairmentJames F Burris, Michael A Tortorici, Maja Mandic, et al.
Critical Care Medicine|December 4, 2008
Moderate hypothermia prevents cardiac arrest-mediated suppression of drug metabolism and induction of interleukin-6 in ratsMichael A Tortorici, Ying Mu, Patrick M Kochanek, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Expert Review of Clinical Pharmacology|May 31, 2014
Kidney function assessment and its role in drug development, review and utilizationMichael A Tortorici, Thomas D Nolin
Critical Care Medicine|September 15, 2007
Effects of hypothermia on drug disposition, metabolism, and response: A focus of hypothermia-mediated alterations on the cytochrome P450 enzyme systemMichael A Tortorici, Patrick M Kochanek, Samuel M Poloyac
Journal of Clinical Pharmacology|January 11, 2012
Design, conduct, analysis, and interpretation of clinical studies in patients with impaired kidney functionMichael A Tortorici, David Cutler, Lei Zhang, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 14, 2018
CSL112 (Apolipoprotein A-I [Human]) Enhances Cholesterol Efflux Similarly in Healthy Individuals and Stable Atherosclerotic Disease PatientsAndreas Gille, Denise D'Andrea, Michael A Tortorici, et al.
European Journal of Clinical Pharmacology|October 12, 2012
The evaluation of potential pharmacokinetic interaction between sirolimus and tacrolimus in healthy volunteersMichael A Tortorici, Virginia Parks, Kyle Matschke, et al.
Immunological Medicine|December 19, 2019
Pharmacokinetic properties of Privigen<sup>®</sup> in Japanese patients with primary immunodeficiencyTomohiro Morio, Gautam Baheti, Michael A Tortorici, et al.
Critical Care Medicine|March 8, 2006
Therapeutic hypothermia-induced pharmacokinetic alterations on CYP2E1 chlorzoxazone-mediated metabolism in a cardiac arrest rat modelMichael A Tortorici, Patrick M Kochanek, Robert R Bies, et al.
Clinical Therapeutics|January 9, 2020
Pharmacometric Analysis of IgPro10 in Japanese and Non-Japanese Patients With Primary ImmunodeficiencyDandan Luo, Gautam Baheti, Michael A Tortorici, et al.
Journal of Clinical Pharmacology|August 20, 2016
Dosage Adjustments Related to Young or Old Age and Organ ImpairmentJames F Burris, Michael A Tortorici, Maja Mandic, et al.
Critical Care Medicine|December 4, 2008
Moderate hypothermia prevents cardiac arrest-mediated suppression of drug metabolism and induction of interleukin-6 in ratsMichael A Tortorici, Ying Mu, Patrick M Kochanek, et al.
Pageof 4